Stereotaxis, Inc.
ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the international leader in revolutionary robotic technologies for the therapy of cardiac arrhythmias, nowadays announced the grand opening of a new robotic electrophysiology system at Broward Well being Healthcare Center in Fort Lauderdale, Florida. Broward Well being is amongst the very first in the nation, and the very first in Florida, to offer you the newest Genesis Robotic Magnetic Navigation Program to treat heart rhythm problems.
“Advancing patient care is our quantity 1 priority, and we are excited to make this one of a kind technologies out there, expanding our electrophysiology capabilities to treat the most complicated heart arrhythmias with heightened precision,” stated Ahmed Osman, M.D., Healthcare Director of Cardiac Electrophysiology.
The Genesis RMN program introduces the rewards of robotic precision and security to cardiac ablation, a widespread, minimally invasive process to treat arrhythmias. Tens of millions of people worldwide endure from arrhythmias – abnormal heart rhythms that outcome when the heart beats also promptly, also gradually, or with an irregular pattern. When left untreated, specific arrhythmias can substantially improve the danger of stroke, heart failure, and sudden cardiac arrest.
“Broward Well being is committed to adopting revolutionary technologies and creating it out there to individuals close to residence,” stated Shane Strum, President & CEO of Broward Well being. “We are proud to be the very first in Florida to introduce this program to additional improve the complete variety of sophisticated cardiac solutions we provide to our neighborhood.”
“We are delighted to operate with Broward Well being as it pioneers this technologies for the advantage of individuals in Florida,” stated David Fischel, Chairman and CEO of Stereotaxis. “We applaud their leadership and appear forward to supporting their efforts to increase patient care and make a preeminent heart rhythm system.”
About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and international leader in revolutionary surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, improvement and delivery of robotic systems, instruments, and info options for the interventional laboratory. These innovations enable physicians deliver unsurpassed patient care with robotic precision and security, expand access to minimally invasive therapy, and improve the productivity, connectivity, and intelligence in the operating area. Stereotaxis technologies has been made use of to treat more than one hundred,000 individuals across the United States, Europe, Asia, and elsewhere. For a lot more info, please check out www.stereotaxis.com
Story continues
This press release involves statements that may well constitute “forward-searching” statements, ordinarily containing the words “believe”, “estimate”, “project”, “count on” or related expressions. Forward-searching statements inherently involve dangers and uncertainties that could bring about actual benefits to differ materially. Elements that would bring about or contribute to such variations involve, but are not restricted to, the Company’s capability to handle costs at sustainable levels, acceptance of the Company’s items in the marketplace, the impact of international financial situations on the capability and willingness of shoppers to acquire its technologies, competitive variables, alterations resulting from healthcare policy, dependence upon third-celebration vendors, timing of regulatory approvals, the effect of pandemics or other disasters, and other dangers discussed in the Company’s periodic and other filings with the Securities and Exchange Commission. By creating these forward-searching statements, the Organization undertakes no obligation to update these statements for revisions or alterations soon after the date of this release. There can be no assurance that the Organization will recognize income associated to its acquire orders and other commitments due to the fact some of these acquire orders and other commitments are topic to contingencies that are outdoors of the Company’s manage and may well be revised, modified, delayed, or canceled.
Stereotaxis Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Monetary Officer
314-678-6100
investors@stereotaxis.com
